Sp1 is an essential transcription factor for LPS-induced tissue factor expression in THP-1 monocytic cells, and nobiletin represses the expression through inhibition of NF-κB, AP-1, and Sp1 activation

被引:29
|
作者
Hirata, Yuki [1 ]
Masuda, Yutaka [1 ]
Kakutani, Hideki [1 ]
Higuchi, Toshiyuki [1 ]
Takada, Kimihiko [1 ]
Ito, Akira [2 ]
Nakagawa, Yoshio [3 ]
Ishii, Hidemi [1 ]
机构
[1] Showa Pharmaceut Univ, Dept Mol & Cell Pathophysiol, Machida, Tokyo 1948543, Japan
[2] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Biochem, Hachioji, Tokyo 1920392, Japan
[3] Tokyo Metropolitan Inst Publ Hlth, Dept Pharmacol, Shinjuku Ku, Tokyo 1690073, Japan
关键词
nobiletin; tissue factor; LPS; NF-kappa B; AP-1; Sp1;
D O I
10.1016/j.bcp.2007.12.019
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nobiletin is a citrus polymethoxylated. flavonoid extracted from Citrus depressa, and has several reported biological effects. In this study, we investigated the effect of nobiletin on bacterial lipopolysaccharicle (LPS)-induced expression of tissue factor (TF), a trigger protein for the blood coagulation cascade, and studied the possible mechanism of TF transcriptional regulation. THP-1 monocytic cells stimulated with LPS showed an increased expression of both TF protein and mRNA levels. However, pretreatment with nobiletin resulted in inhibition of LPS-induced expression of both TF protein and mRNA in a dose-dependent manner. Electrophoretic mobility shift assays revealed that binding of nuclear proteins from LPS-stimulated THP-1 cells to the NF-kappa B or AP-1 binding motif was increased as compared to non-stimulated control cells. Such increased binding activities were significantly reduced by pretreatment with nobiletin. Binding activity of nuclear proteins to the Sp1 binding motif was observed irrespective of LPS stimulation, but Sp1 activation was inhibited by nobiletin treatment of the cells. Treatment of THP-1 cells with Sp1-specific small interfering RNA (Sp1 siRNA) abolished the ability of LPS to induce TF activity. A similar reduction in the level of TF mRNA was also observed upon treatment of cells with Sp1 siRNA. These studies reveal that constitutive Sp1 activation is an essential event for transcriptional activation of TF, and nobiletin prevents LPS-induced TF expression by inhibiting NF-kappa B, AP-1, and Sp1 activation. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:1504 / 1514
页数:11
相关论文
共 50 条
  • [41] ACTIVATION OF THE AIDS RETROVIRUS PROMOTER BY THE CELLULAR TRANSCRIPTION FACTOR, SP1
    JONES, KA
    KADONAGA, JT
    LUCIW, PA
    TJIAN, R
    SCIENCE, 1986, 232 (4751) : 755 - 759
  • [42] SYNERGISTIC ACTIVATION OF A HUMAN PROMOTER INVIVO BY TRANSCRIPTION FACTOR SP1
    ANDERSON, GM
    FREYTAG, SO
    MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (04) : 1935 - 1943
  • [43] Sp1 mediates phorbol ester (PMA)-induced expression of membrane-bound guanylyl cyclase GC-A in human monocytic THP-1 cells
    Mitkiewicz, Malgorzata
    Bac, Bernadeta
    Kuropatwa, Marianna
    Kurowska, Ewa
    Matuszyk, Janusz
    Siednienko, Jakub
    ACTA BIOCHIMICA POLONICA, 2018, 65 (03) : 409 - 414
  • [44] Verotoxin-1 induces tissue factor expression in human umbilical vein endothelial cells through activation of NF-κB/Rel and AP-1
    Ishii, H
    Takada, K
    Higuchi, T
    Sugiyama, J
    THROMBOSIS AND HAEMOSTASIS, 2000, 84 (04) : 712 - 721
  • [45] Insulin-like growth factor-I controls BRCA1 gene expression through activation of transcription factor Sp1
    Maor, S.
    Papa, M. Z.
    Yarden, R. I.
    Friedman, E.
    Lerenthal, Y.
    Lee, S. W.
    Mayer, D.
    Werner, H.
    HORMONE AND METABOLIC RESEARCH, 2007, 39 (03) : 179 - 185
  • [46] Sp1 and NF-κB regulate transcription of biglycan in hepatic stellate cells.
    Rippe, RA
    Scanga, AE
    Schrum, LW
    Keku, T
    Iozzo, RV
    Brenner, DA
    HEPATOLOGY, 1998, 28 (04) : 344A - 344A
  • [47] MUTATED RAS INDUCED PLD1 GENE EXPRESSION THROUGH INCREASED Sp1 TRASCRIPTION FACTOR
    Gao, Siqiang
    Murakami, Masashi
    Ito, Hiromi
    Furuhata, Ayako
    Yoshida, Kayo
    Tagawa, Yoko
    Hagiwara, Kazumi
    Takagi, Akira
    Kojima, Tetsuhito
    Suzuki, Motoshi
    Banno, Yoshiko
    Nozawa, Yoshinori
    Murate, Takashi
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2009, 71 (3-4): : 127 - 136
  • [48] Dimethylarginine dimethylaminohydrolase 2 increases vascular endothelial growth factor expression through Sp1 transcription factor in endothelial cells
    Hasegawa, Kazuhiro
    Wakino, Shu
    Tanaka, Toru
    Kimoto, Masumi
    Tatematsu, Satoru
    Kanda, Takeshi
    Yoshioka, Kyoko
    Homma, Koichiro
    Sugano, Naoki
    Kurabayashi, Masahiko
    Saruta, Takao
    Hayashi, Koichi
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (07) : 1488 - 1494
  • [49] ROLE OF EPIGENETIC REGULATION AND SP1 TRANSCRIPTION FACTOR ON DP1 RECEPTOR EXPRESSION IN OSTEOARTHRITIS
    Alsabri, Sami G.
    Najar, Mehdi
    Guedi, Gadid G.
    Merimi, Makram
    Lavoie, Frederic
    Grabs, Detlev
    Pelletier, Jean-Pierre
    Martel-Pelletie, Johanne R.
    Benderdour, Mohamed
    Fahmi, Hassan
    OSTEOARTHRITIS AND CARTILAGE, 2024, 32 : S382 - S382
  • [50] Inhibition of glutaminase expression increases Sp1 phosphorylation and Sp1/Sp3 transcriptional activity in Ehrlich tumor cells
    Segura, JA
    Donadio, AC
    Lobo, C
    Matés, JM
    Márquez, J
    Alonso, FJ
    CANCER LETTERS, 2005, 218 (01) : 91 - 98